VIEW MORE
Liquid biopsy is increasingly stepping up as a non-invasive approach in detecting and tracking circulating tumor DNA (ctDNA) in blood...
Novel ACT-Discover liquid biopsy shows 30% increased sensitivity in detecting tumor DNA in blood
VIEW MORE
The operation was led by the Botin Foundation Mind the Gap programme, with participation from BStartup of Banco Sabadell. The...
Oniria Therapeutics closes €1.28 million seed funding round
VIEW MORE
Today, the journals Nature and Nature Genetics publish two studies led by Dr Francisco Martínez Jiménez, current head of VHIO’s...
Two studies published today in Nature and Nature Genetics compare the complete genome of more than 7,000 primary and metastatic tumours and describe the global genomic differences between them, as well as their interaction with the immune system

Latest News

Published in The New England Journal of Medicine (1) results of the phase 3 COSMIC-313 trial show that the addition...

The power of three: triplet drug combination slows disease progression in patients with advanced kidney cancer
Published in The New England Journal of Medicine (1) results of the phase 3 COSMIC-313 trial show that the addition...

This year’s Scientific Report is themed Advancing cancer care through transformative team science. It celebrates VHIO’s model of multidisciplinary and...

VHIO’s Scientific Report 2022: Advancing cancer care through transformative team science
This year’s Scientific Report is themed Advancing cancer care through transformative team science. It celebrates VHIO’s model of multidisciplinary and...

Liquid biopsy is increasingly stepping up as a non-invasive approach in detecting and tracking circulating tumor DNA (ctDNA) in blood...

Novel ACT-Discover liquid biopsy shows 30% increased sensitivity in detecting tumor DNA in blood
Liquid biopsy is increasingly stepping up as a non-invasive approach in detecting and tracking circulating tumor DNA (ctDNA) in blood...

The operation was led by the Botin Foundation Mind the Gap programme, with participation from BStartup of Banco Sabadell. The...

Oniria Therapeutics closes €1.28 million seed funding round
The operation was led by the Botin Foundation Mind the Gap programme, with participation from BStartup of Banco Sabadell. The...

Research Programs

PRECLINICAL & TRANSLATIONAL RESEARCH
Cellular Plasticity and Cancer Group

Our group focuses on the interplay between cellular plasticity, stem cells and cancer. Cellular plasticity is recognized today as a critical feature of cancer cells that enables them to transit between different cellular states, including reversible transitions.

Cellular Plasticity and Cancer Group
PRECLINICAL & TRANSLATIONAL RESEARCH
Growth Factors Group

We focus our research on mechanisms of resistance to targeted therapies and most importantly, how to overcome it by showing that breast cancers resistant to T-DM1, an antibody-drug conjugate ADC)- can be efficiently treated with the second generation ADC SYD985 (Nadal-Serrano et al.).

Growth Factors Group
CORE TECHNOLOGIES
Cancer Genomics Group

VHIO’s Cancer Genomics Group serves as a Core Technology laboratory. We are also dedicated to translational research as well as the development of novel genomic tests.

Cancer Genomics Group

PRINCIPAL RESEARCHERS

Héctor_Palmer
Héctor G. Palmer
Stem Cells and Cancer Group

Our group studies the mechanisms that enable tumors to evade effective treatments and progress to advanced stages.

Joan_Seoane
Joan Seoane
Gene Expression and Cancer Group

We study primary brain tumors and brain metastasis; some of the most aggressive of all cancers. Both glioblastoma and brain…

JUDIT_BALMAÑA
Judith Balmaña
Hereditary Cancer Genetics Group

We focus on the clinical development of PARP inhibitors (PARPi) in early gBRCA1/2 breast cancer, and novel combinations in the…

César_Serrano
César Serrano
Sarcoma Translational Research Group

Our group focuses on the study of sarcomas with oncogenic dependency on specific drivers of disease. Among these, gastrointestinal stromal…

Events

Friday 2 June 23 - 12:00 PM scientific-seminars Seminars Ramon Alemany | Cancer Virotherapy with Oncolytic Adenoviruses
Tuesday 6 June 23 - 06:00 PM Patients Severo Ochoa Efectos secundarios. Hablamos de experiencias, compartimos realidades
Wednesday 14 June 23 - 11:00 AM Patients Diet and breast cancer. We discover how diet can help you improve symptoms and side effects
Monday 26 June 23 - 03:00 PM Patients Severo Ochoa ¿Cómo abordar el cáncer renal? Una mirada integral
Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.